Segall Bryant & Hamill LLC Acquires Shares of 288,100 Azenta, Inc. (NASDAQ:AZTA)

Segall Bryant & Hamill LLC bought a new position in shares of Azenta, Inc. (NASDAQ:AZTA) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 288,100 shares of the company’s stock, valued at approximately $14,405,000. Segall Bryant & Hamill LLC owned about 0.63% of Azenta at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Prudential Financial Inc. grew its position in Azenta by 164.9% during the 4th quarter. Prudential Financial Inc. now owns 45,868 shares of the company’s stock worth $2,293,000 after purchasing an additional 28,553 shares during the last quarter. LPL Financial LLC boosted its stake in shares of Azenta by 31.4% during the fourth quarter. LPL Financial LLC now owns 50,342 shares of the company’s stock worth $2,590,000 after buying an additional 12,033 shares during the period. KLP Kapitalforvaltning AS purchased a new position in shares of Azenta during the fourth quarter worth about $530,000. Sei Investments Co. increased its position in Azenta by 59.0% in the 4th quarter. Sei Investments Co. now owns 152,536 shares of the company’s stock valued at $7,627,000 after acquiring an additional 56,590 shares during the period. Finally, American Century Companies Inc. raised its stake in Azenta by 10.8% during the 4th quarter. American Century Companies Inc. now owns 99,210 shares of the company’s stock valued at $4,960,000 after acquiring an additional 9,640 shares during the last quarter. 99.08% of the stock is owned by institutional investors and hedge funds.

Azenta Price Performance

Shares of AZTA stock opened at $37.15 on Wednesday. Azenta, Inc. has a 1-year low of $35.56 and a 1-year high of $63.58. The business’s fifty day moving average price is $46.13 and its 200 day moving average price is $46.49. The firm has a market capitalization of $1.70 billion, a PE ratio of -12.47 and a beta of 1.52.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Equities research analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on AZTA. Evercore ISI boosted their target price on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. TD Cowen raised shares of Azenta to a “hold” rating in a research note on Thursday, February 27th. Stephens restated an “overweight” rating and issued a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. Finally, Needham & Company LLC lifted their target price on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $58.75.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.